Cambridge Investment Research Advisors, Inc.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1419186
FAIRFIELD, IA
Position in NBIX
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$1,132,251
+$929,958 QoQ
Shares Held
6,718
+353.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#56
of 205 holders
Holding Since
Mar 2024
4 quarters on record
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $28,056,483 across 19 Drug Manufacturers - Specialty & Generic names. NBIX ranks #8 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
64,199 | $7,122,237 | |
| 2 | PCRX |
Pacira BioSciences, Inc.
|
127,996 | $3,247,258 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
5,625 | $3,047,793 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
87,650 | $2,969,582 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
79,024 | $2,739,762 | |
| 6 | ZTS |
Zoetis Inc.
|
34,463 | $2,476,511 | |
| 7 | VTRS |
Viatris Inc
|
140,834 | $2,236,443 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
This page
|
6,718 | $1,132,251 |
All Filings in NBIX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,132,251 | 6,718 | Shares | Sole | 2026-07-27 | |
| 2024-12-31 | $202,293 | 1,482 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $350,920 | 2,549 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $340,938 | 2,472 | Shares | Sole | 2024-04-24 | |
| No filing history on record for this holder in this stock. | ||||||